Medindia
Medindia LOGIN REGISTER
Advertisement

New study of ultrasound enhancing agents in echocardiography reaffirms safety profile of LUMASON® (sulfur hexafluoride lipid-type A microspheres) for injectable suspension, for intravenous use or intravesical use

Monday, July 15, 2019 General News
Advertisement
Data show only one non-serious adverse event reported with LUMASON ultrasound enhancing agent in 2,137 administrations

Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close